25 XP   0   0   10

Nu-Med Plus Inc
Buy, Hold or Sell?

Let's analyse Nu-Med Plus Inc together

PenkeI guess you are interested in Nu-Med Plus Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nu-Med Plus Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Nu-Med Plus Inc

I send you an email if I find something interesting about Nu-Med Plus Inc.

Quick analysis of Nu-Med Plus Inc (30 sec.)










What can you expect buying and holding a share of Nu-Med Plus Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
31.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-2.5%

For what price can you sell your share?

Current Price per Share
$0.04
Expected price per share
$0.035 - $0.09
How sure are you?
50%

1. Valuation of Nu-Med Plus Inc (5 min.)




Live pricePrice per Share (EOD)

$0.04

Intrinsic Value Per Share

$0.03 - $0.04

Total Value Per Share

$0.03 - $0.03

2. Growth of Nu-Med Plus Inc (5 min.)




Is Nu-Med Plus Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$146.7k-$192.3k$70.9k58.4%

How much money is Nu-Med Plus Inc making?

Current yearPrevious yearGrowGrow %
Making money-$31.3k-$32.5k$1.1k3.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Nu-Med Plus Inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#311 / 339

Most Revenue
#326 / 339

Most Profit
#122 / 339

Most Efficient
#130 / 339

What can you expect buying and holding a share of Nu-Med Plus Inc? (5 min.)

Welcome investor! Nu-Med Plus Inc's management wants to use your money to grow the business. In return you get a share of Nu-Med Plus Inc.

What can you expect buying and holding a share of Nu-Med Plus Inc?

First you should know what it really means to hold a share of Nu-Med Plus Inc. And how you can make/lose money.

Speculation

The Price per Share of Nu-Med Plus Inc is $0.0413. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nu-Med Plus Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nu-Med Plus Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nu-Med Plus Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-1.7%0.00-0.9%0.00-1.0%0.00-6.1%0.00-2.1%
Usd Book Value Change Per Share0.00-0.4%0.00-0.6%0.000.5%0.00-0.3%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.4%0.00-0.6%0.000.5%0.00-0.3%0.00-0.2%
Usd Price Per Share0.04-0.02-0.02-0.31-0.34-
Price to Earnings Ratio-14.52--17.43--3.89--23.69--27.22-
Price-to-Total Gains Ratio-222.12--108.64--36.46-1,164.54-845.47-
Price to Book Ratio-22.39--15.98--11.15--392.02--276.91-
Price-to-Total Gains Ratio-222.12--108.64--36.46-1,164.54-845.47-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0413
Number of shares24213
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (24213 shares)-6.23-2.91
Gains per Year (24213 shares)-24.92-11.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-25-350-12-22
20-50-600-23-34
30-75-850-35-46
40-100-1100-46-58
50-125-1350-58-70
60-150-1600-70-82
70-174-1850-81-94
80-199-2100-93-106
90-224-2350-105-118
100-249-2600-116-130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%2.027.00.06.9%2.027.00.06.9%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%9.020.00.031.0%9.020.00.031.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%9.020.00.031.0%9.020.00.031.0%

Fundamentals of Nu-Med Plus Inc

About Nu-Med Plus Inc

Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. It serves hospitals, health systems, and the medical community. The company was incorporated in 2011 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-04-02 17:29:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Nu-Med Plus Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nu-Med Plus Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Nu-Med Plus Inc to the Medical Devices industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nu-Med Plus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-129.3%+129.3%
5Y-129.3%10Y-89.1%-40.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.2%+11.2%
TTM--19.6%+19.6%
YOY--14.4%+14.4%
5Y-129.3%-21.3%-108.0%
10Y-89.1%-24.8%-64.3%
1.1.2. Return on Assets

Shows how efficient Nu-Med Plus Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nu-Med Plus Inc to the Medical Devices industry mean.
  • -420.6% Return on Assets means that Nu-Med Plus Inc generated $-4.21 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nu-Med Plus Inc:

  • The MRQ is -420.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -163.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-420.6%TTM-163.6%-257.0%
TTM-163.6%YOY-795.4%+631.9%
TTM-163.6%5Y-347.3%+183.8%
5Y-347.3%10Y-244.3%-103.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-420.6%-4.0%-416.6%
TTM-163.6%-4.5%-159.1%
YOY-795.4%-4.8%-790.6%
5Y-347.3%-4.0%-343.3%
10Y-244.3%-5.2%-239.1%
1.1.3. Return on Equity

Shows how efficient Nu-Med Plus Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nu-Med Plus Inc to the Medical Devices industry mean.
  • 0.0% Return on Equity means Nu-Med Plus Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nu-Med Plus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-35.9%+35.9%
5Y-35.9%10Y-77.0%+41.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.9%+3.9%
TTM--5.6%+5.6%
YOY--5.9%+5.9%
5Y-35.9%-6.1%-29.8%
10Y-77.0%-7.1%-69.9%

1.2. Operating Efficiency of Nu-Med Plus Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nu-Med Plus Inc is operating .

  • Measures how much profit Nu-Med Plus Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nu-Med Plus Inc to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nu-Med Plus Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-134.3%+134.3%
5Y-134.3%10Y-92.6%-41.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--22.8%+22.8%
TTM--17.1%+17.1%
YOY--13.4%+13.4%
5Y-134.3%-19.2%-115.1%
10Y-92.6%-24.0%-68.6%
1.2.2. Operating Ratio

Measures how efficient Nu-Med Plus Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Nu-Med Plus Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y1.343-1.343
5Y1.34310Y0.926+0.417
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.428-1.428
TTM-1.426-1.426
YOY-1.503-1.503
5Y1.3431.440-0.097
10Y0.9261.371-0.445

1.3. Liquidity of Nu-Med Plus Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nu-Med Plus Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.08 means the company has $0.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Nu-Med Plus Inc:

  • The MRQ is 0.084. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.203. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.084TTM0.203-0.119
TTM0.203YOY0.158+0.045
TTM0.2035Y0.830-0.627
5Y0.83010Y0.840-0.010
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0842.787-2.703
TTM0.2032.763-2.560
YOY0.1583.488-3.330
5Y0.8303.617-2.787
10Y0.8403.514-2.674
1.3.2. Quick Ratio

Measures if Nu-Med Plus Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nu-Med Plus Inc to the Medical Devices industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nu-Med Plus Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.006-0.006
TTM0.006YOY-+0.006
TTM0.0065Y0.241-0.235
5Y0.24110Y306.884-306.643
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.539-1.539
TTM0.0061.660-1.654
YOY-2.139-2.139
5Y0.2412.300-2.059
10Y306.8842.255+304.629

1.4. Solvency of Nu-Med Plus Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nu-Med Plus Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nu-Med Plus Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 11.91 means that Nu-Med Plus Inc assets are financed with 1,190.6% credit (debt) and the remaining percentage (100% - 1,190.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nu-Med Plus Inc:

  • The MRQ is 11.906. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 7.303. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ11.906TTM7.303+4.603
TTM7.303YOY35.796-28.493
TTM7.3035Y10.809-3.507
5Y10.80910Y12.067-1.257
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ11.9060.389+11.517
TTM7.3030.386+6.917
YOY35.7960.338+35.458
5Y10.8090.442+10.367
10Y12.0670.460+11.607
1.4.2. Debt to Equity Ratio

Measures if Nu-Med Plus Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nu-Med Plus Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nu-Med Plus Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.184-0.184
5Y0.18410Y0.945-0.761
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.559-0.559
TTM-0.560-0.560
YOY-0.478-0.478
5Y0.1840.624-0.440
10Y0.9450.674+0.271

2. Market Valuation of Nu-Med Plus Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Nu-Med Plus Inc generates.

  • Above 15 is considered overpriced but always compare Nu-Med Plus Inc to the Medical Devices industry mean.
  • A PE ratio of -14.52 means the investor is paying $-14.52 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nu-Med Plus Inc:

  • The EOD is -14.841. Based on the earnings, the company is expensive. -2
  • The MRQ is -14.517. Based on the earnings, the company is expensive. -2
  • The TTM is -17.428. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.841MRQ-14.517-0.323
MRQ-14.517TTM-17.428+2.911
TTM-17.428YOY-3.894-13.535
TTM-17.4285Y-23.688+6.259
5Y-23.68810Y-27.220+3.532
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-14.841-1.037-13.804
MRQ-14.517-1.578-12.939
TTM-17.428-2.041-15.387
YOY-3.894-2.971-0.923
5Y-23.688-2.058-21.630
10Y-27.220-1.463-25.757
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nu-Med Plus Inc:

  • The EOD is -196.152. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -191.878. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -61.974. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-196.152MRQ-191.878-4.275
MRQ-191.878TTM-61.974-129.904
TTM-61.974YOY176.123-238.097
TTM-61.9745Y-39.062-22.912
5Y-39.06210Y-47.992+8.930
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-196.152-1.007-195.145
MRQ-191.878-1.544-190.334
TTM-61.974-3.018-58.956
YOY176.123-6.339+182.462
5Y-39.062-4.928-34.134
10Y-47.992-4.950-43.042
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nu-Med Plus Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -22.39 means the investor is paying $-22.39 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Nu-Med Plus Inc:

  • The EOD is -22.894. Based on the equity, the company is expensive. -2
  • The MRQ is -22.395. Based on the equity, the company is expensive. -2
  • The TTM is -15.983. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.894MRQ-22.395-0.499
MRQ-22.395TTM-15.983-6.412
TTM-15.983YOY-11.153-4.830
TTM-15.9835Y-392.021+376.038
5Y-392.02110Y-276.912-115.109
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-22.8941.987-24.881
MRQ-22.3952.379-24.774
TTM-15.9832.444-18.427
YOY-11.1533.215-14.368
5Y-392.0213.833-395.854
10Y-276.9124.163-281.075
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Nu-Med Plus Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.000+41%0.000-185%0.000-34%0.000-66%
Book Value Per Share---0.002-0.001-17%-0.002+31%-0.001-41%-0.003+41%
Current Ratio--0.0840.203-59%0.158-47%0.830-90%0.840-90%
Debt To Asset Ratio--11.9067.303+63%35.796-67%10.809+10%12.067-1%
Debt To Equity Ratio----0%-0%0.184-100%0.945-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.0010.000-46%0.000-43%-0.003+265%-0.001+25%
Free Cash Flow Per Share--0.0000.000+288%0.000+125%-0.001+1405%-0.011+21522%
Free Cash Flow To Equity Per Share--0.0000.000+288%0.000-111%0.000-35%-0.010+19635%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.035--------
Intrinsic Value_10Y_min--0.029--------
Intrinsic Value_1Y_max---0.001--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max--0.001--------
Intrinsic Value_3Y_min--0.001--------
Intrinsic Value_5Y_max--0.007--------
Intrinsic Value_5Y_min--0.006--------
Market Cap3359692.885+2%3286479.2381972701.028+67%1685947.580+95%25108213.290-87%27582750.385-88%
Net Profit Margin----0%-0%-1.2930%-0.8910%
Operating Margin----0%-0%-1.3430%-0.9260%
Operating Ratio----0%-0%1.343-100%0.926-100%
Pb Ratio-22.894-2%-22.395-15.983-29%-11.153-50%-392.021+1650%-276.912+1136%
Pe Ratio-14.841-2%-14.517-17.428+20%-3.894-73%-23.688+63%-27.220+88%
Price Per Share0.041+2%0.0400.024+67%0.021+95%0.309-87%0.339-88%
Price To Free Cash Flow Ratio-196.152-2%-191.878-61.974-68%176.123-209%-39.062-80%-47.992-75%
Price To Total Gains Ratio-227.068-2%-222.119-108.642-51%-36.459-84%1164.541-119%845.467-126%
Quick Ratio---0.006-100%-0%0.241-100%306.884-100%
Return On Assets---4.206-1.636-61%-7.954+89%-3.473-17%-2.443-42%
Return On Equity----0%-0%-0.3590%-0.7700%
Total Gains Per Share--0.0000.000+41%0.000-185%0.000-34%0.000-66%
Usd Book Value---146751.000-121371.000-17%-192312.000+31%-86996.550-41%-206982.862+41%
Usd Book Value Change Per Share--0.0000.000+41%0.000-185%0.000-34%0.000-66%
Usd Book Value Per Share---0.002-0.001-17%-0.002+31%-0.001-41%-0.003+41%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.0010.000-46%0.000-43%-0.003+265%-0.001+25%
Usd Free Cash Flow---4282.000-16597.250+288%-9620.000+125%-64443.500+1405%-925872.345+21522%
Usd Free Cash Flow Per Share--0.0000.000+288%0.000+125%-0.001+1405%-0.011+21522%
Usd Free Cash Flow To Equity Per Share--0.0000.000+288%0.000-111%0.000-35%-0.010+19635%
Usd Market Cap3359692.885+2%3286479.2381972701.028+67%1685947.580+95%25108213.290-87%27582750.385-88%
Usd Price Per Share0.041+2%0.0400.024+67%0.021+95%0.309-87%0.339-88%
Usd Profit---56596.000-31381.500-45%-32541.750-43%-206578.900+265%-71135.793+26%
Usd Revenue----0%-0%469.200-100%323.586-100%
Usd Total Gains Per Share--0.0000.000+41%0.000-185%0.000-34%0.000-66%
 EOD+6 -2MRQTTM+14 -13YOY+14 -125Y+10 -2010Y+16 -14

3.2. Fundamental Score

Let's check the fundamental score of Nu-Med Plus Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.841
Price to Book Ratio (EOD)Between0-1-22.894
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.084
Debt to Asset Ratio (MRQ)Less than111.906
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-4.206
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Nu-Med Plus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.808
Ma 20Greater thanMa 500.052
Ma 50Greater thanMa 1000.047
Ma 100Greater thanMa 2000.038
OpenGreater thanClose0.041
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets13
Total Liabilities160
Total Stockholder Equity-147
 As reported
Total Liabilities 160
Total Stockholder Equity+ -147
Total Assets = 13

Assets

Total Assets13
Total Current Assets13
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 7
Total Current Assets  (as reported)13
Total Current Assets  (calculated)7
+/- 7
Long-term Assets
Property Plant Equipment 90
Long-term Assets  (as reported)0
Long-term Assets  (calculated)90
+/- 90

Liabilities & Shareholders' Equity

Total Current Liabilities160
Long-term Liabilities0
Total Stockholder Equity-147
Total Current Liabilities
Short Long Term Debt 100
Accounts payable 54
Total Current Liabilities  (as reported)160
Total Current Liabilities  (calculated)154
+/- 6
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)-147
Total Stockholder Equity (calculated)0
+/- 147
Other
Capital Stock84
Common Stock Shares Outstanding 81,348
Net Debt 93
Net Invested Capital -47
Net Working Capital -147



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
36
350
317
459
407
325
337
552
423
155
53
84
46
47
852
650
557
285
89
51
22
8
8
3
80
59
37
14
13
13143759803882251892855576508524746845315542355233732540745931735036
   > Total Current Assets 
12
328
264
409
360
282
293
512
386
116
21
46
14
21
833
624
538
271
80
35
12
8
6
3
80
59
37
14
13
13143759803681235802715386248332114462111638651229328236040926432812
       Cash And Cash Equivalents 
12
318
264
409
351
275
288
168
168
23
16
42
7
18
6
31
189
139
73
32
12
3
0
1
73
53
30
11
7
71130537310312327313918931618742162316816828827535140926431812
       Net Receivables 
0
506,386
670,977
704,527
552,703
832,823
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
00040000000000000000000832,823552,703704,527670,977506,3860
       Other Current Assets 
0
11
221,477
209,138
9
7
0
0
0
0
0
0
0
0
0
0
349
132
7
0
0
5
0
0
0
0
0
0
0
00000005007132349000000000079209,138221,477110
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
38
32
38
32
26
19
25
20
14
10
17
10
0
2
0
0
0
0
0
0
00000020101710142025192632383238000000000
       Property Plant Equipment 
23
21
54
50
47
43
44
41
37
38
32
38
32
26
19
25
12
9
8
17
10
0
2
84
90
84
84
84
90
908484849084201017891225192632383238374144434750542123
       Goodwill 
0
1,228,059
1,256,014
1,251,986
1,251,825
2,381,620
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000002,381,6201,251,8251,251,9861,256,0141,228,0590
       Intangible Assets 
0
439,507
442,962
429,069
410,857
1,410,302
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001,410,302410,857429,069442,962439,5070
       Other Assets 
0
1,511
1,511
8,534
8,868
1,511
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001,5118,8688,5341,5111,5110
> Total Liabilities 
4,475
386
414
414
338
346
362
358
374
379
360
387
416
415
441
428
89
94
91
121
155
197
256
273
143
150
152
146
160
1601461521501432732561971551219194894284414154163873603793743583623463384144143864,475
   > Total Current Liabilities 
4,475
386
400
402
328
338
355
354
374
379
360
387
416
415
431
419
80
85
91
121
155
197
256
273
143
150
152
146
160
1601461521501432732561971551219185804194314154163873603793743543553383284024003864,475
       Short-term Debt 
4,400
310
334
9
9
9
9
9
11
239
230
230
230
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000023023023023911999993343104,400
       Short Long Term Debt 
4,400
310
334
9
9
9
9
9
11
239
230
230
230
230
230
230
0
0
0
0
0
0
0
0
100
100
100
100
100
1001001001001000000000023023023023023023023911999993343104,400
       Accounts payable 
75
76
4
2
4
10
21
18
16
31
14
30
54
50
80
50
72
80
89
39
54
78
119
129
42
48
49
41
54
544149484212911978543989807250805054301431161821104247675
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
5
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
00000000002000000005000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
9
9
0
0
0
0
0
0
0
0
0
0
0
00000000000999900000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
0
0
0
0
0
0
0
0
0
0
0
00000000000990000000000000000
       Other Liabilities 
0
0
0
0
0
10,617
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000010,61700000
       Deferred Long Term Liability 
0
137,495
142,116
138,383
93,451
91,101
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000091,10193,451138,383142,116137,4950
> Total Stockholder Equity
-4,439
-37
-97
45
68
-21
-25
194
49
-225
-307
-303
-370
-367
412
222
468
191
-2
-70
-132
-189
-247
-270
-63
-91
-116
-132
-147
-147-132-116-91-63-270-247-189-132-70-2191468222412-367-370-303-307-22549194-25-216845-97-37-4,439
   Common Stock
37
37
37
38
38
38
38
41
41
42
42
42
44
44
50
50
51
79
79
79
79
79
79
81
81
0
81
0
0
0081081817979797979795150504444424242414138383838373737
   Retained Earnings -9,825-9,768-9,752-9,728-9,699-9,742-9,684-9,626-9,569-9,457-9,339-9,096-8,739-8,246-7,792-6,884-6,730-6,520-6,370-6,122-5,693-5,352-4,826-4,652-4,505-4,352-4,209-4,093-8,082
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,432
9,208
9,258
0
0
0
0
0
0
0
0
0
0
00000000009,2589,2088,4320000000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
25
439
494
651
806
865
924
789
849
894
1,010
1,114
466
572
21
197
724
0
0
0
0
0
0
0
0
0
0
0
0
000000000000724197215724661,1141,01089484978992486580665149443925



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-121
Operating Income-121-121
 
Operating Expense (+$)
Research Development0
Selling General Administrative121
Selling And Marketing Expenses0
Operating Expense121121
 
Net Interest Income (+$)
Interest Income0
Interest Expense-5
Other Finance Cost-0
Net Interest Income-5
 
Pretax Income (+$)
Operating Income-121
Net Interest Income-5
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-126-121
EBIT - interestExpense = -5
-126
-121
Interest Expense5
Earnings Before Interest and Taxes (EBIT)0-121
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-126
Tax Provision-0
Net Income From Continuing Ops-126-126
Net Income-126
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net05
 

Technical Analysis of Nu-Med Plus Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nu-Med Plus Inc. The general trend of Nu-Med Plus Inc is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nu-Med Plus Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nu-Med Plus Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.07 < 0.09.

The bearish price targets are: 0.0404 > 0.0404 > 0.035.

Tweet this
Nu-Med Plus Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nu-Med Plus Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nu-Med Plus Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nu-Med Plus Inc. The current macd is -0.00140002.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nu-Med Plus Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Nu-Med Plus Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Nu-Med Plus Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Nu-Med Plus Inc Daily Moving Average Convergence/Divergence (MACD) ChartNu-Med Plus Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nu-Med Plus Inc. The current adx is 19.18.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Nu-Med Plus Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Nu-Med Plus Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nu-Med Plus Inc. The current sar is 0.05343292.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Nu-Med Plus Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nu-Med Plus Inc. The current rsi is 42.81. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Nu-Med Plus Inc Daily Relative Strength Index (RSI) ChartNu-Med Plus Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nu-Med Plus Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nu-Med Plus Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Nu-Med Plus Inc Daily Stochastic Oscillator ChartNu-Med Plus Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nu-Med Plus Inc. The current cci is -130.76961296.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Nu-Med Plus Inc Daily Commodity Channel Index (CCI) ChartNu-Med Plus Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nu-Med Plus Inc. The current cmo is -26.54087396.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Nu-Med Plus Inc Daily Chande Momentum Oscillator (CMO) ChartNu-Med Plus Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nu-Med Plus Inc. The current willr is -79.28176796.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Nu-Med Plus Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Nu-Med Plus Inc Daily Williams %R ChartNu-Med Plus Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nu-Med Plus Inc.

Nu-Med Plus Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nu-Med Plus Inc. The current atr is 0.01040242.

Nu-Med Plus Inc Daily Average True Range (ATR) ChartNu-Med Plus Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nu-Med Plus Inc. The current obv is 26,755,117.

Nu-Med Plus Inc Daily On-Balance Volume (OBV) ChartNu-Med Plus Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nu-Med Plus Inc. The current mfi is 24.08.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Nu-Med Plus Inc Daily Money Flow Index (MFI) ChartNu-Med Plus Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nu-Med Plus Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Nu-Med Plus Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nu-Med Plus Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.808
Ma 20Greater thanMa 500.052
Ma 50Greater thanMa 1000.047
Ma 100Greater thanMa 2000.038
OpenGreater thanClose0.041
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nu-Med Plus Inc with someone you think should read this too:
  • Are you bullish or bearish on Nu-Med Plus Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nu-Med Plus Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nu-Med Plus Inc

I send you an email if I find something interesting about Nu-Med Plus Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Nu-Med Plus Inc.

Receive notifications about Nu-Med Plus Inc in your mailbox!